查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2006251

C型臂市场：依系统类型、检测器类型、技术、应用和最终用户划分－2026-2032年全球市场预测

C-arms Market by System Type, Detector Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，C 型臂市场价值将达到 27.9 亿美元，到 2026 年将成长到 30.4 亿美元，到 2032 年将达到 50.2 亿美元，复合年增长率为 8.76%。

主要市场统计数据
基准年 2025 27.9亿美元
预计年份：2026年 30.4亿美元
预测年份 2032 50.2亿美元
复合年增长率 (%) 8.76%

详细说明最新的 C 型臂技术、临床效用、采用因素以及影响 C 型臂在医疗机构中引入的营运重点。

C型臂影像平台在众多介入专科领域持续发挥核心作用，可在微创手术中实现即时萤光成像。这些系统部署于医院手术室、混合手术室和门诊手术室，其在器械引导、定位验证和减少手术併发症的功能构成了现代临床工作流程的基础。随着微创手术在临床路径中日益重要，对可靠、高解析度影像的需求也日益增长，这种影像方式能够简化手术流程并与电子健康记录无缝整合。

这显然整合了技术进步、软体整合和操作变革，从根本上重新定义了 C 型臂系统的规格製定、采购和支援方式。

C型臂产业正经历一系列变革，这些变革正在重新定义产品蓝图和临床预期。检测器技术和影像处理技术的进步提高了影像品质和低剂量性能，使得在以往缺乏高端影像支援的环境中开展更复杂的手术成为可能。同时，模组化和小型化使得行动系统在许多应用情境下能够达到与固定安装系统相媲美的效能，从而实现了更灵活的部署模式，更能适应不断变化的医疗服务模式。

对 2025 年关税变化如何重组整个 C-ARM 生态系统的供应链、采购计画和筹资策略进行全面检验。

美国2025年实施的贸易政策调整和关税措施引发了各行各业的多方面反应，从采购决策到临床环境中的采购时间表均受到影响。部分进口零件关税的提高迫使原始设备製造商（OEM）重新评估其全球供应链，加速了关于扩大近岸外包、多源采购和本地组装的讨论，以维持价格竞争力并降低前置作业时间风险。因此，采购团队调整了资本规划中的缓衝资金，并寻求提高零件来源和供应商韧性方面的透明度。

针对特定领域的情报，解读应用、系统类型、检测器配置、最终用户购买模式以及从类比技术过渡到数位技术的趋势。

细分市场层面的趋势揭示了不同的需求模式，这些模式有助于产品设计、销售策略和临床定位。临床需求因应用领域而异。在心血管外科手术中，高时间分辨率和稳定的透视性能对于血管导航至关重要；而在胃肠病学和泌尿系统中，则需要具有灵活C臂角度调节功能的紧凑型系统来适应内视镜手术流程。在整形外科和疼痛管理领域，影像清晰度是骨骼和植入清晰显示的首要考虑因素；而在血管外科手术中，则需要广角成像和先进的对比控制。这些应用领域驱动的差异会影响功能优先顺序、培训要求和服务合约。

从区域观点解释法规环境、基础设施成熟度和本地生产能力如何影响全球市场对 C 型臂的采用。

区域趋势影响着科技的应用路径和商业策略，法律规范、医疗服务模式和製造地等方面的差异是造成这种差异的原因。在美洲，临床需求集中在大规模医院网路和快速发展的门诊手术中心，这得益于成熟的分销管道和对生命週期服务合约的高度重视。该地区的报销框架和资本核准流程正在推动投资，从而提高营运效率并带来可衡量的临床改善，进而促使人们对整合成像和软体功能产生更大的兴趣。

企业层面的策略分析，说明了决定供应商竞争优势的产品模组化、服务差异化、伙伴关係策略和不断演变的商业模式。

领先供应商的企业策略强调端到端的价值提案，将硬体、软体和服务结合。各公司正投资于模组化产品架构，以便适应未来的检测器升级和软体增强，从而延长仪器的使用寿命，并透过维护和软体授权获得持续的收入。与导航、机器人和分析服务提供者的策略合作也日益普遍，从而实现能够应对复杂手术流程并创造差异化临床价值的整合解决方案。

供应商和医疗保健系统可采取的策略重点，以加强供应链韧性、加速技术转型以及实现服务和软体能力的货币化。

产业领导企业应优先考虑几项策略性倡议，以巩固市场地位并加速临床应用。首先，他们需要透过多元化采购和区域组装系统来增强供应链韧性，从而降低贸易和关税波动带来的风险。此外，还应结合透明的供应商资讯和合约条款，以减少前置作业时间和成本的不确定性。其次，他们应加快向平板检测器技术和软体功能的转型，这些技术和功能能够显着提高影像品质和剂量效率，同时透过为现有部署提供改装方案来维护客户关係。

为了检验可靠的研究结果，我们采用了一种透明、严谨的混合方法研究途径，将对临床医生和采购负责人的初步访谈与法规和技术方面的二手资讯的三角检验相结合。

本研究途径结合了定性和定量方法，以确保获得全面且经得起验证的见解。主要研究包括对介入检验、放射科负责人、手术室经理、采购负责人以及涵盖各类急诊和门诊机构的服务部门主管进行结构化访谈和引导式讨论​​。这些对话探讨了临床需求、采购标准、服务期望和实际使用模式，并将技术和商业性的观察结果与实际经验相结合。

简明扼要地总结了 C 型臂领域的技术进步、供应链现状以及供应商和医疗机构面临的策略挑战。

总而言之，C型臂系统处于临床需求、技术创新和营运限制的交汇点。检测器现代化、软体整合以及采购模式的转变正在重塑医疗系统和门诊机构评估影像平台的方式。收费系统驱动的供应链变化凸显了製造弹性和采购透明度的必要性，而法规和基础设施的区域差异则要求制定本地化的商业化策略。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：C型臂市场依系统类型划分

  • 固定的
  • 活动

第九章：检测器类型分類的C型臂市场

  • 平板检测器
  • 影像增强器
    • 12英吋
    • 16英寸
    • 9吋

第十章：C型臂市场：依技术划分

  • 模拟
  • 数位的

第十一章 C型臂市场：按应用领域划分

  • 循环系统
  • 紧急状况
  • 胃肠病学
  • 整形外科
  • 疼痛管理
  • 泌尿系统
  • 血管外科

第十二章 C型臂市场：依最终用户划分

  • 门诊手术中心
  • 医院

第十三章 C型臂市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 C型臂市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 C型臂市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国C型臂市场

第十七章：中国C臂市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Airbus SE
  • Aviation Industry Corporation of China, Ltd.
  • BAE Systems plc
  • China Aerospace Science and Industry Corporation Limited
  • China Electronics Technology Group Corporation
  • China North Industries Group Corporation Limited
  • China State Shipbuilding Corporation Limited
  • General Dynamics Corporation
  • General Electric Company
  • L3Harris Technologies, Inc.
  • Leonardo SpA
  • Lockheed Martin Corporation
  • Mitsubishi Heavy Industries, Ltd.
  • Northrop Grumman Corporation
  • Rheinmetall AG
  • RTX Corporation
  • Saab AB
  • State Corporation Rostec
  • Thales Group（Thales SA）
  • The Boeing Company
Product Code: MRR-B1685377A596

The C-arms Market was valued at USD 2.79 billion in 2025 and is projected to grow to USD 3.04 billion in 2026, with a CAGR of 8.76%, reaching USD 5.02 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.79 billion
Estimated Year [2026] USD 3.04 billion
Forecast Year [2032] USD 5.02 billion
CAGR (%) 8.76%

An informed introduction to contemporary C-arm technology, clinical utility, procurement drivers, and operational priorities that shape adoption across care settings

C-arm imaging platforms remain central to a wide range of interventional specialties, enabling real-time fluoroscopic visualization during minimally invasive procedures. These systems are deployed across hospital operating rooms, hybrid suites, and outpatient surgical settings where their ability to guide instrumentation, confirm placement, and reduce procedural complications has become foundational to modern clinical workflows. As clinical pathways increasingly favor minimally invasive approaches, demand for dependable, high-resolution imaging that integrates seamlessly into procedure ergonomics and electronic health records has intensified.

Technological evolution has shifted vendor focus from analogue image intensifiers toward digital flat panel detectors, improved dose management, and software-driven image processing. Meanwhile, serviceability, total cost of ownership, and lifecycle support are prominent considerations for procurement teams constrained by capital planning cycles and clinical throughput requirements. Regulatory oversight and procurement protocols vary by geography, shaping adoption rhythms and vendor go-to-market models. In this context, clarity around application-specific requirements, system form factor choices, and detector technology trade-offs is essential for clinical leaders and business executives alike to align technology investments with patient outcomes and operational efficiency goals.

A clear synthesis of technology advancements, software integration, and operational shifts that are fundamentally redefining how C-arm systems are specified, purchased, and supported

The C-arm landscape is experiencing a suite of concurrent transformative shifts that are redefining product road maps and clinical expectations. Advances in detector technology and image processing have pushed image quality and low-dose performance forward, enabling more complex procedures in settings that previously lacked high-end imaging support. At the same time, modularity and miniaturization have allowed mobile systems to gain functional parity with fixed installations for many use cases, enabling flexible deployment models that better align with evolving care delivery patterns.

Software is now a strategic differentiator: integration with navigation, robotics, and AI-enabled image enhancement is expanding the clinical envelope and creating new value streams tied to recurring software licenses and service agreements. In parallel, hospital planning increasingly emphasizes hybrid operating rooms that blend imaging and interventional capability, which drives demand for systems designed for interoperability and sterility management. Operational considerations such as uptime, remote diagnostics, and optimized service logistics are rising in importance, particularly as providers seek to protect clinical throughput and reduce unplanned capital expenditure. Consequently, manufacturers and service providers are adapting to a landscape where hardware excellence must be paired with robust software ecosystems, flexible financing models, and resilient supply chains.

A comprehensive examination of how tariff changes in 2025 reshaped supply chains, procurement timelines, and sourcing strategies across the C-arm ecosystem

Trade policy adjustments and tariff implementations in the United States during 2025 have generated a multifaceted industry response that extends from sourcing decisions to clinical procurement timing. Increased duties on certain imported components have pressured original equipment manufacturers to re-evaluate global supply chains, accelerating conversations about nearshoring, multi-sourcing, and increased local assembly to preserve price competitiveness and mitigate lead-time risk. As a result, procurement teams have adjusted capital planning buffers and sought greater transparency around component provenance and supplier resilience.

Vendors have reacted by shifting manufacturing footprints, renegotiating supplier contracts, and optimizing bills of materials to reduce exposure to tariffed inputs. These changes have incentivized design-for-manufacturing and supplier consolidation strategies that favor components with stable trade classifications. Meanwhile, distributors and service providers are recalibrating stocking policies and spare parts inventories to avoid service disruptions that could compromise operating room schedules. Clinical and procurement leaders are prioritizing systems with predictable maintenance models and strong service networks to prevent throughput erosion.

Regulatory compliance and import documentation now factor more prominently into total procurement timelines, especially for complex purchases requiring multi-site approvals. The cumulative operational effect includes extended evaluation periods and a heightened emphasis on contractual protections around price adjustments and lead times. In this environment, institutions that proactively engage with suppliers on supply chain transparency and lifecycle support can better safeguard clinical continuity and capital efficiency.

Segment-specific intelligence that decodes application, system type, detector configurations, end-user purchasing patterns, and analog-to-digital technology adoption dynamics

Segment-level dynamics reveal differentiated demand patterns that inform product design, sales strategy, and clinical positioning. Based on application, clinical needs vary markedly: cardiology procedures emphasize high temporal resolution and consistent fluoroscopic performance for vascular navigation, whereas gastroenterology and urology require compact systems with flexible C-arm angulation to accommodate endoscopic workflows. Orthopedics and pain management prioritize image clarity for bone and implant visualization, and vascular surgery demands extended field-of-view imaging and advanced contrast management. These application-driven distinctions influence feature prioritization, training requirements, and service contracts.

Based on system type, procurement choices are driven by the trade-off between the stability and higher throughput of fixed installations and the flexibility and lower footprint of mobile units. Facilities with multiple procedure types or constrained capital budgets tend to favor mobile systems that can be redeployed across rooms, while high-volume interventional centers and hybrid ORs typically specify fixed platforms for integrated sterility and imaging performance.

Based on detector type, there is a clear technical divergence between flat panel detectors and image intensifiers. Flat panel detectors are increasingly preferred for their uniform image quality, lower distortion, and improved dose efficiency, but image intensifiers remain relevant in specific legacy fleets and cost-sensitive deployments. Within the image intensifier category, preferences for 12 inch, 16 inch, or 9 inch formats depend on procedure types and field-of-view requirements, with larger intensifiers serving broader anatomical coverage and smaller formats supporting targeted interventions.

Based on end user, ambulatory surgical centers and hospitals present different purchasing profiles: ambulatory centers prioritize throughput, rapid turnaround, and capital efficiency, while hospitals emphasize integration, redundancy, and broad clinical versatility. Based on technology, analog platforms continue to serve legacy workflows and retrofit markets, but digital systems are leading new deployments due to superior image processing, integration capability, and enabling digital services. Understanding these segmentation vectors enables vendors and purchasers to align clinical performance expectations with procurement strategy and long-term service commitments.

A region-by-region perspective that explains how regulatory environments, infrastructure maturity, and local manufacturing shape C-arm adoption across global markets

Regional dynamics shape adoption pathways and commercial strategy, with variation driven by regulatory frameworks, healthcare delivery models, and manufacturing footprints. In the Americas, clinical demand is concentrated in large hospital networks and growing outpatient surgical centers, supported by established distribution channels and a strong emphasis on lifecycle service agreements. Reimbursement frameworks and capital approval processes in the region incentivize investments that deliver operational efficiencies and measurable clinical improvements, which in turn elevate interest in integrated imaging and software-enabled functionality.

In Europe, Middle East & Africa, heterogeneous regulatory regimes and variable infrastructure maturity create a patchwork of opportunity. Western Europe tends to adopt advanced imaging capabilities within tertiary hospitals and hybrid suites, while other regional markets prioritize durable, serviceable systems that can function reliably in constrained environments. Middle Eastern healthcare investment has driven demand for high-end imaging in flagship centers, whereas parts of Africa present long-term growth potential tied to investments in basic fluoroscopy and training infrastructure.

The Asia-Pacific region combines high-volume demand with strong local manufacturing and supply chain networks. Adoption is being propelled by expanding hospital capacity, the proliferation of outpatient surgical facilities, and competitive vendor landscapes that feature both global OEMs and agile regional manufacturers. In many Asia-Pacific markets, procurement decisions balance capital constraints with the need for robust service coverage, making locally supported service models and retrofit upgrade paths particularly valuable. Across regions, vendors that tailor deployment models, financing options, and service footprints to local regulatory and operational realities achieve stronger uptake and long-term customer retention.

Strategic company-level analysis describing product modularity, service differentiation, partnership strategies, and evolving commercial models that define vendor competitiveness

Corporate strategies among leading suppliers emphasize end-to-end value propositions that combine hardware, software, and service. Companies are investing in modular product architectures that accommodate detector upgrades and software enhancements over time, which helps extend device lifecycles and supports recurring revenue through maintenance and software licensing. Strategic partnerships with navigation, robotics, and analytics providers are increasingly common, enabling combined solutions that address complex procedural workflows and create differentiated clinical value.

Aftermarket service performance is a competitive battleground. Firms that offer predictive maintenance, remote diagnostics, and rapid spare-parts logistics sustain higher uptime and stronger client relationships. In response, some suppliers are expanding direct service footprints or partnering with regional service organizations to improve responsiveness. Additionally, pricing models are evolving: flexible financing, pay-per-use constructs for high-utilization environments, and bundled service contracts are being used to lower procurement barriers and align vendor incentives with clinical outcomes.

Emerging and regional players are competing on cost, localized support, and niche clinical fit, while incumbents defend through innovations in detector technology, software ecosystems, and proven clinical evidence. Mergers and strategic alliances within the broader imaging and interventional markets continue to reshape competitive positioning, with an emphasis on building comprehensive interventional ecosystems rather than singular product offerings.

Actionable strategic priorities for vendors and health systems to enhance supply resilience, accelerate technology migration, and monetize service and software capabilities

Industry leaders should prioritize several strategic initiatives to secure market position and accelerate clinical adoption. First, invest in supply chain resilience through multi-sourcing and regional assembly capabilities to reduce exposure to trade and tariff volatility. This approach should be complemented by transparent supplier mapping and contractual clauses that mitigate lead-time and cost uncertainty. Second, accelerate the transition to flat panel detector technology and software-enabled features that demonstrably improve image quality and dose efficiency, while offering retrofit paths for legacy installed bases to preserve customer relationships.

Third, adopt service-centric commercial models that emphasize uptime guarantees, remote diagnostics, and outcome-linked service agreements. Tying value to measurable operational and clinical metrics strengthens procurement conversations and supports longer-term revenue stability. Fourth, expand partnerships with navigation and analytics providers to embed imaging systems within broader procedural ecosystems, which increases switching costs and enhances clinical value. Fifth, tailor regional go-to-market approaches: offer financing and localized service packages in emerging markets, and prioritize integration and hybrid OR capability in centers of excellence.

Finally, invest in clinician education and training programs that reduce user variability and demonstrate clinical utility for new features. By combining technology investments with strong service models and clinician enablement, companies can differentiate on total cost of ownership, clinical throughput, and patient safety outcomes, translating product innovation into sustainable commercial advantage.

A transparent and rigorous mixed-methods research approach combining primary clinician and procurement interviews with secondary regulatory and technical source triangulation for robust insight validation

The research approach combined qualitative and quantitative techniques to ensure comprehensive and validated insights. Primary research included structured interviews and guided discussions with interventional physicians, radiology leaders, operating room managers, procurement officers, and service executives across a spectrum of acute care and ambulatory facilities. These conversations explored clinical requirements, procurement criteria, service expectations, and real-world usage patterns to ground technical and commercial observations in frontline experience.

Secondary research leveraged peer-reviewed clinical literature, regulatory approval documentation, patent filings, clinical trial registries, and publicly available company disclosures to contextualize technological trends and product development pathways. Secondary sources were triangulated with primary findings to validate technology adoption narratives and to identify areas of divergence between clinical expectations and vendor positioning. Data validation steps included cross-referencing interview input with documented product specifications and service offering descriptions, and circulating key findings to a panel of industry advisors for critique and refinement.

Limitations were acknowledged and addressed through targeted follow-up interviews and sensitivity checks. The methodology emphasized transparency in source attribution and reproducibility of analytic steps, enabling stakeholders to interrogate assumptions and adapt insights to their internal decision frameworks.

A concise conclusion tying together technology evolution, supply chain realities, and strategic imperatives for vendors and provider organizations in the C-arm space

In summary, C-arm systems sit at the intersection of clinical need, technological innovation, and operational constraint. The combined effects of detector modernization, software integration, and shifting procurement paradigms are reshaping how health systems and ambulatory providers evaluate imaging platforms. Tariff-driven supply chain shifts underscore the need for manufacturing agility and procurement transparency, while regional differences in regulation and infrastructure demand tailored commercialization strategies.

For clinical leaders and vendor executives, the imperative is clear: align product development with clinician workflows, ensure service models deliver predictable uptime, and present value in terms that resonate with capital planners and quality leaders. Vendors that marry hardware excellence with robust software ecosystems and flexible commercial terms will be better positioned to capture durable customer relationships. Meanwhile, providers that demand clarity on lifecycle support, integration capability, and proven clinical benefit will protect throughput and patient outcomes as adoption patterns evolve. The path forward favors strategic alignment between technology capability and operational reality, enabling safer, more efficient interventional care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. C-arms Market, by System Type

  • 8.1. Fixed
  • 8.2. Mobile

9. C-arms Market, by Detector Type

  • 9.1. Flat Panel Detector
  • 9.2. Image Intensifier
    • 9.2.1. 12 Inch
    • 9.2.2. 16 Inch
    • 9.2.3. 9 Inch

10. C-arms Market, by Technology

  • 10.1. Analog
  • 10.2. Digital

11. C-arms Market, by Application

  • 11.1. Cardiology
  • 11.2. Emergency
  • 11.3. Gastroenterology
  • 11.4. Orthopedics
  • 11.5. Pain Management
  • 11.6. Urology
  • 11.7. Vascular Surgery

12. C-arms Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. C-arms Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. C-arms Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. C-arms Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States C-arms Market

17. China C-arms Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Airbus SE
  • 18.6. Aviation Industry Corporation of China, Ltd.
  • 18.7. BAE Systems plc
  • 18.8. China Aerospace Science and Industry Corporation Limited
  • 18.9. China Electronics Technology Group Corporation
  • 18.10. China North Industries Group Corporation Limited
  • 18.11. China State Shipbuilding Corporation Limited
  • 18.12. General Dynamics Corporation
  • 18.13. General Electric Company
  • 18.14. L3Harris Technologies, Inc.
  • 18.15. Leonardo S.p.A.
  • 18.16. Lockheed Martin Corporation
  • 18.17. Mitsubishi Heavy Industries, Ltd.
  • 18.18. Northrop Grumman Corporation
  • 18.19. Rheinmetall AG
  • 18.20. RTX Corporation
  • 18.21. Saab AB
  • 18.22. State Corporation Rostec
  • 18.23. Thales Group (Thales S.A.)
  • 18.24. The Boeing Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL C-ARMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL C-ARMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL C-ARMS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL C-ARMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL C-ARMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL C-ARMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL C-ARMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL C-ARMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL C-ARMS MARKET SIZE, BY FIXED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL C-ARMS MARKET SIZE, BY FIXED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL C-ARMS MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL C-ARMS MARKET SIZE, BY MOBILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL C-ARMS MARKET SIZE, BY MOBILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL C-ARMS MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL C-ARMS MARKET SIZE, BY 12 INCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL C-ARMS MARKET SIZE, BY 12 INCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL C-ARMS MARKET SIZE, BY 12 INCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL C-ARMS MARKET SIZE, BY 16 INCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL C-ARMS MARKET SIZE, BY 16 INCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL C-ARMS MARKET SIZE, BY 16 INCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL C-ARMS MARKET SIZE, BY 9 INCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL C-ARMS MARKET SIZE, BY 9 INCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL C-ARMS MARKET SIZE, BY 9 INCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL C-ARMS MARKET SIZE, BY ANALOG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL C-ARMS MARKET SIZE, BY ANALOG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL C-ARMS MARKET SIZE, BY ANALOG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL C-ARMS MARKET SIZE, BY DIGITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL C-ARMS MARKET SIZE, BY DIGITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL C-ARMS MARKET SIZE, BY DIGITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL C-ARMS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL C-ARMS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL C-ARMS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL C-ARMS MARKET SIZE, BY EMERGENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL C-ARMS MARKET SIZE, BY EMERGENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL C-ARMS MARKET SIZE, BY EMERGENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL C-ARMS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL C-ARMS MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL C-ARMS MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL C-ARMS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL C-ARMS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL C-ARMS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL C-ARMS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL C-ARMS MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL C-ARMS MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL C-ARMS MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL C-ARMS MARKET SIZE, BY VASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL C-ARMS MARKET SIZE, BY VASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL C-ARMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL C-ARMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL C-ARMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL C-ARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL C-ARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. GCC C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. GCC C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. GCC C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 131. GCC C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. GCC C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. G7 C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. G7 C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. G7 C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 152. G7 C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. G7 C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NATO C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NATO C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. NATO C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 159. NATO C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NATO C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA C-ARMS MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)